Effects of oral contraceptives on metabolic profile in women with polycystic ovary syndrome: A meta-analysis comparing products containing cyproterone acetate with third generation progestins
Metabolism: clinical and experimental | 25 Jul 2017
M Amiri, F Ramezani Tehrani, F Nahidi, A Kabir, F Azizi and E Carmina
Although oral contraceptives (OCs) are the most common treatment in women with polycystic ovary syndrome (PCOS), their effects and safety on the metabolic profiles of these patients are relatively unknown. In this meta-analysis the effects of the different durations (from 3months to 1year) of OC treatment using cyproterone acetate (CA) or third generation progestins on metabolic profile of patients with PCOS were assessed.
* Data courtesy of Altmetric.com